Alphabet’s New Model & Novo’s Lawsuit
Summary
Hosts Travis Hoy, Lou Whiteman, and John Quast discuss Alphabet’s new Gemini AI model, noting that while it faces criticism from enthusiasts, its cost-efficiency may appeal to broader users. They analyze the lawsuit between Novo Nordisk and Eli Lilly over GLP-1 drug marketing, highlighting Eli Lilly’s market dominance and higher valuation. Finally, they examine GE Vernova’s strong earnings driven by data center energy demand, cautioning that "picks and shovels" stocks are now overvalued compared to core tech companies.
Topics discussed
Earnings season kickoff and Alphabet's Gemini AI model release
Commercial break: Range Rover Sport advertisement
Novo Nordisk sues Eli Lilly over GLP-1 drug marketing and competition
Commercial breaks: Vanguard and Claude AI advertisements
GE Vernova earnings, data center energy demand, and valuation concerns
Listen ad-free on Castria